Article

(2021) SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage. Front Immunol. p. 705772. ISSN 1664-3224

(2020) Design of an engineered ACE2 as a novel therapeutics against COVID-19. Journal of Theoretical Biology. p. 11. ISSN 0022-5193

(2020) Liothyronine could block the programmed death-ligand 1 (PDL1) activity: an e-Pharmacophore modeling and virtual screening study. Journal of Receptors and Signal Transduction. p. 9. ISSN 1079-9893

(2020) Proposed Multi-linear Regression Model to Identify Cyclooxygenase-2 Selective Active Pharmaceutical Ingredients. Journal of Pharmaceutical Innovation. p. 7. ISSN 1872-5120

(2020) Structure Based Screening for Inhibitory Therapeutics of CTLA-4 Unveiled New Insights About Biology of ACTH. International Journal of Peptide Research and Therapeutics. pp. 849-859. ISSN 1573-3149